G. Emons
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Hypothalamic control of reproductive hormones
- Ovarian function and disorders
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Endometrial and Cervical Cancer Treatments 7
- Uterine Myomas and Treatments 2
- Pregnancy and preeclampsia studies 1
-
- Ovarian cancer diagnosis and treatment 5
- Hypothalamic control of reproductive hormones 3
- Co-authors
- Carsten Gründker (3 shared papers)Lars Schlotawa (2 shared papers)Volker Viereck (3 shared papers)K.-D. Schulz (1 shared paper)Karin Kast (1 shared paper)S. Seitz (1 shared paper)Olaf Ortmann (1 shared paper)H Prömpeler (1 shared paper)
In The Last Decade
G. Emons
16 papers receiving 422 citations
Peers
Comparison fields: 5 of 41
- Reproductive Medicine 157
- Obstetrics and Gynecology 107
- Cancer Research 75
- Oncology 91
- Genetics 86
Countries citing papers authored by G. Emons
This map shows the geographic impact of G. Emons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Emons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Emons more than expected).
Fields of papers citing papers by G. Emons
This network shows the impact of papers produced by G. Emons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Emons. The network helps show where G. Emons may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Emons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 110 | |
| 2 | 2004 | 78 | |
| 3 | 2020 | 43 | |
| 4 | 2002 | 37 | |
| 5 | 2002 | 33 | |
| 6 | 2001 | 31 | |
| 7 | 2004 | 29 | |
| 8 | 2000 | 28 | |
| 9 | 2006 | 18 | |
| 10 | Docetaxel is effective in the treatment of metastatic endometrial cancer. | 2000 | 7 |
| 11 | 2012 | 7 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 3 | |
| 14 | 2009 | 2 | |
| 15 | 2002 | 1 | |
| 16 | Arbeitsgemeinschaft Gynäkologische Onkologie. Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4 | 2007 | 1 |
| 17 | 2004 | 0 |
About G. Emons
G. Emons is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Genetics, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 435 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Hypothalamic control of reproductive hormones (3 papers), Estrogen and related hormone effects (2 papers), Uterine Myomas and Treatments (2 papers), Pregnancy and preeclampsia studies (1 paper), Maternal and fetal healthcare (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Reproductive Medicine (157 citations), Obstetrics and Gynecology (107 citations), Cancer Research (75 citations), Oncology (91 citations) and Genetics (86 citations). G. Emons has collaborated with scholars based in Germany, Austria and Belgium. Frequent co-authors include Carsten Gründker, Lars Schlotawa, Volker Viereck, K.-D. Schulz, Karin Kast, S. Seitz, Olaf Ortmann, H Prömpeler, Martin Hellriegel and Willi Sauerbrei. Their work appears in journals such as European Journal of Endocrinology, Annals of Oncology, Recent results in cancer research, Archives of Gynecology and Obstetrics and Human Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.